CardiOCare's project logo

An Interdisciplinary Approach for the Management of the Elderly Multimorbid Patient with Breast Cancer Therapy Induced Cardiac Toxicity

Publications

Papers in international journals (full-paper reviewed)

  1. Brown C, Mantzaris M, Nicolaou E, et al. A systematic review of miRNAs as biomarkers for chemotherapy-induced cardiotoxicity in breast cancer patients reveals potentially clinically informative panels as well as key challenges in miRNA research. Cardio-Oncology. 2022;8(1):16. doi:10.1186/s40959-022-00142-1| Lay summary (in PDF)
  2. Gkikas S, Tsiknakis M. Automatic assessment of pain based on deep learning methods: A systematic review. Comput Methods Programs Biomed. 2023;231:107365. doi:10.1016/j.cmpb.2023.107365 | Lay summary (in PDF)
  3. Alexandraki A, Papageorgiou E, Zacharia M, et al. New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review. Cancers (Basel). 2023;15(13):3290. doi:10.3390/cancers15133290 | Lay summary (in PDF)

Conferences

Papers in Proceedings of International Conferences (full-paper reviewed)


  1. Tsiouris K, Mitsis A, Grigoriadis G, et al. Risk Stratification for Cardiotoxicity in Breast Cancer Patients: Predicting Early Decline of LVEF After Treatment. 2023 IEEE 45th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)

Papers in Proceedings of International Conferences (extended abstract reviewed)


  1. Casini C, Monzani D, Masiero M, et al. Incorporating psycho-social factors in cancer treatment adverse events studies. Ann Oncol. 2022;33:S1199. (poster presentation) doi:10.1016/j.annonc.2022.07.1535
  2. Karanasiou G, Grigoriadis G, Alexandraki A, et al. A multimodal approach for the management of co-morbid cardiotoxicity in the elderly breast cancer patients. Eur J Cancer. 2022;175:S40. (poster presentation) doi:10.1016/S0959-8049(22)01456-3

Poster presentations


  1. Casini C, Monzani D, Masiero M, et al. Incorporating psycho-social factors in cancer treatment adverse events studies. Ann Oncol. 2022;33:S1199. | Poster in PDF
  2. Karanasiou G, Grigoriadis G, Alexandraki A, et al. A multimodal approach for the management of co-morbid cardiotoxicity in the elderly breast cancer patients. Eur J Cancer. 2022;175:S40. | Poster in PDF
  3. Kalliatakis G, Manikis G, Karanasiou G, et al. Automated  Left Ventricular Ejection Fraction (LVEF) measurement in 2D Echocardiography using DL-based Segmentation. 2023 IEEE 20th International Symposium on Biomedical Imaging (ISBI) | Poster in PDF
  4. Karanasiou G, Koumakis L, Sfakianakis S, et. al. CARDIOCARE: An integrated platform for the management of elderly multimorbid patients with breast cancer therapy induced cardiac toxicity. 2023 IEEE 45th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) | Poster in PDF

Highlights

CARDIOCARE in the Cardiovascular Imaging Congress

CARDIOCARE in the Cardiovascular Imaging Congress

Dr. Kalliopi Keramida presented CARDIOCARE during her lecture on "Monitoring cardiovascular complications during cancer therapy" in the Cardiotoxicity Session in the Cardiovascular Imaging Congress that held from 12th to 13th of April 2024 in Athens. The overall...

CARDIOCARE in the ESC Spring Summit 2024

CARDIOCARE in the ESC Spring Summit 2024

CARDIOCARE was communicated in the ESC Spring Summit 2024 that took place on the 7th and the 8th of March 2024 at the European Heart House, in Nice, France. Read more: https://www.escardio.org/Spring-Summit